Although the detection of phosphorylated HER2 (pHER2) in metastatic PCa tumor biopsies supported previous clinical studies and was proposed as an adaptive mechanism to prolonged ADT exposure, it showed little clinical benefit in this context (32, 34–37). Here, ERBB2 is linked to posterior cortical atrophy.